18m
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Evvy, the precision women's health company, today announced the launch of the Evvy UTI+ Test, a comprehensive at-home urine test that uses PCR technology to detect 12 key uropathogens and 7 antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback